CRL Charles River Laboratories International, Inc. Stock Quote

CRL [NYSE]

Charles River Laboratories International, Inc.

Healthcare | Diagnostics & Research | USA

Index	-	P/E	46.71	EPS (ttm)	6.00	Insider Own	0.70%	Shs Outstand	49.70M	Perf Week	4.97%
Market Cap	13.59B	Forward P/E	31.63	EPS next Y	8.86	Insider Trans	-16.20%	Shs Float	49.01M	Perf Month	11.75%
Income	301.50M	PEG	3.45	EPS next Q	2.11	Inst Own	96.20%	Short Float	1.40%	Perf Quarter	22.30%
Sales	2.82B	P/S	4.81	EPS this Y	13.30%	Inst Trans	0.07%	Short Ratio	2.23	Perf Half Y	41.36%
Book/sh	38.17	P/B	7.34	EPS next Y	12.84%	ROA	5.90%	Target Price	265.71	Perf Year	78.80%
Cash/sh	5.03	P/C	55.73	EPS next 5Y	13.53%	ROE	17.40%	52W Range	95.58 - 284.60	Perf YTD	12.13%
Dividend	-	P/FCF	30.45	EPS past 5Y	13.40%	ROI	8.50%	52W High	-1.55%	Beta	1.10
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	15.10%	Gross Margin	36.70%	52W Low	193.14%	ATR	6.73
Employees	17100	Current Ratio	1.40	Sales Q/Q	11.30%	Oper. Margin	14.60%	RSI (14)	71.55	Volatility	2.16% 2.67%
Optionable	Yes	Debt/Eq	1.06	EPS Q/Q	38.60%	Profit Margin	10.70%	Rel Volume	0.55	Prev Close	281.24
Shortable	Yes	LT Debt/Eq	1.04	Earnings	Oct 29 BMO	Payout	0.00%	Avg Volume	308.46K	Price	280.18
Recom	1.90	SMA20	6.99%	SMA50	13.46%	SMA200	34.79%	Volume	169,428	Change	-0.38%

Dec-16-20

Downgrade

Citigroup

Buy → Neutral

$270 → $250

Sep-10-20

Upgrade

Jefferies

Hold → Buy

$254

Jul-01-20

Upgrade

BofA Securities

Neutral → Buy

$192

May-13-20

Upgrade

UBS

Neutral → Buy

$177 → $200

Apr-21-20

Downgrade

Jefferies

Buy → Hold

$139

Mar-27-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$152

Mar-02-20

Initiated

Deutsche Bank

Buy

$190

Feb-18-20

Upgrade

Wolfe Research

Peer Perform → Outperform

Jan-10-20

Upgrade

Goldman

Neutral → Buy

$143 → $179

Jan-08-20

Initiated

Wells Fargo

Overweight

$180

Jan-07-20

Initiated

Citigroup

Buy

$185

Oct-18-19

Downgrade

BofA/Merrill

Buy → Neutral

$150

Jun-10-19

Initiated

SVB Leerink

Outperform

$155

Apr-30-19

Resumed

Evercore ISI

Outperform

$160

Dec-14-18

Initiated

Deutsche Bank

Buy

Oct-09-18

Initiated

UBS

Neutral

Aug-23-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jul-17-18

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

Jun-15-18

Upgrade

KeyBanc Capital Mkts

Sector Weight → Overweight

Feb-14-18

Upgrade

SunTrust

Hold → Buy

Jan-21-21 11:57PM	Estimating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL) Simply Wall St.
Jan-20-21 08:30AM	Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call Business Wire
Jan-15-21 12:57PM	Ariel Investments, Still Hopeful for Charles River Lab (CRL) to Continue Positive Momentum Insider Monkey
Jan-14-21 08:00AM	Charles River Partners with JADE Biomedical to Expand Biologics Capabilities Business Wire
Jan-11-21 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Jan-06-21 04:03PM	Charles River Labs Eyes 'SuperHuman' Gains As Breakout Nears Investor's Business Daily
Jan-04-21 07:00AM	Charles River Laboratories Acquires Distributed Bio Business Wire
Dec-25-20 02:44PM	Is CRL A Good Stock To Buy Now? Insider Monkey
Dec-23-20 12:34AM	If You Had Bought Charles River Laboratories International (NYSE:CRL) Stock Five Years Ago, You Could Pocket A 214% Gain Today Simply Wall St.
Dec-21-20 01:42AM	Toshiba Corporation -- Moody's withdraws Toshiba's B1 and Not Prime ratings for business reasons Moody's
Dec-16-20 12:16PM	Is Charles River Laboratories (CRL) a Smart Long-term Buy? Insider Monkey
Dec-09-20 08:00AM	Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies Business Wire
Nov-27-20 12:43AM	Is Now An Opportune Moment To Examine Charles River Laboratories International, Inc. (NYSE:CRL)? Simply Wall St.
Nov-20-20 03:07PM	Charles River Laboratories Int'l, Inc. -- Moody's upgrades Charles River's CFR to Ba1; outlook stable Moody's
Nov-19-20 12:45PM	Charles River (CRL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Nov-12-20 08:00AM	Charles River and PathoQuest Strengthen Strategic Partnership Business Wire
Nov-09-20 08:30AM	Charles River Laboratories to Present at Upcoming Investor Conferences Business Wire -5.35%
Nov-05-20 09:15AM	Charles River (CRL) Soars to 52-Week High, Time to Cash Out? Zacks
Nov-03-20 12:45PM	3 Reasons Growth Investors Will Love Charles River (CRL) Zacks
Nov-01-20 08:20AM	Earnings Beat: Charles River Laboratories International, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Oct-30-20 04:31AM	Charles River Laboratories International Inc (CRL) Q3 2020 Earnings Call Transcript Motley Fool
Oct-29-20 09:00PM	Toshiba Honored with Five Accolades at GOOD DESIGN AWARD 2020 PR Newswire
07:00AM	Charles River Laboratories Announces Third-Quarter 2020 Results Business Wire
Oct-28-20 12:26PM	Healthcare Stock Q3 Earnings Due on Oct 29: NVCR, CRL & More Zacks
Oct-27-20 06:03PM	Were Hedge Funds Right About Crowding Into Charles River Laboratories (CRL)? Insider Monkey
Oct-26-20 06:53AM	Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-22-20 12:34PM	Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
12:10PM	Can Charles River (CRL) Keep the Earnings Surprise Streak Alive? Zacks
Oct-18-20 09:00PM	Toshiba launches Quantum Key Distribution (QKD) System Business PR Newswire
Oct-17-20 12:19AM	Toshiba Corporation -- Moody's announces completion of a periodic review of ratings of Toshiba Corporation Moody's
Oct-16-20 09:15AM	Charles River Laboratories Adds George Llado to Board of Directors Business Wire
Oct-13-20 08:30AM	Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call Business Wire
Oct-07-20 12:45PM	Charles River (CRL) is an Incredible Growth Stock: 3 Reasons Why Zacks
Sep-26-20 09:51AM	How Good Is Charles River Laboratories International, Inc. (NYSE:CRL), When It Comes To ROE? Simply Wall St.
Sep-23-20 11:49AM	Western Digital Stock Spikes On Speculation It May Split Into Two Barrons.com
Sep-21-20 02:52PM	Buy Western Digital Stock, Analyst Says. Kioxias IPO Will Show Its True Valuation. Barrons.com
Sep-15-20 04:03PM	Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day Investor's Business Daily
03:11PM	Stocks Climb Broadly But Apple Quiet After It Unveils Products Investor's Business Daily
02:25PM	Charles River Labs Shakes Off Covid-19 Impact To Record High And Stock Of The Day Investor's Business Daily
11:36AM	Charles River Labs Breaks Out Investor's Business Daily Video
Sep-13-20 08:00PM	Market Digest: GNRC, AAP, CRL, LULU, RY, EXC Argus Research
08:00PM	Analyst Report: Charles River Laboratories Int Argus Research
Sep-09-20 09:35AM	Hedge Funds Have Never Been This Bullish On Charles River Laboratories (CRL) Insider Monkey
Sep-08-20 08:30AM	Charles River Laboratories to Present at September Investor Conferences Business Wire
Aug-31-20 08:59AM	How Is Charles River Laboratories International's (NYSE:CRL) CEO Paid Relative To Peers? Simply Wall St.
Aug-28-20 11:20AM	Edited Transcript of CRL.N earnings conference call or presentation 6-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Aug-07-20 02:00AM	World's First Development and Demonstration of a Quantum Cryptographic Communication Technology Applied System for Genomic Medicine PR Newswire
Aug-05-20 05:00PM	Charles River Laboratories International Inc (CRL) Q2 2020 Earnings Call Transcript Motley Fool +6.89%
09:05AM	Charles River Laboratories (CRL) Q2 Earnings and Revenues Beat Estimates Zacks
07:53AM	Charles River: Q2 Earnings Insights Benzinga
07:21AM	Charles River Laboratories International, Inc. (NYSE:CRL) Shares Could Be 34% Above Their Intrinsic Value Estimate Simply Wall St.
07:00AM	Charles River Laboratories Announces Second-Quarter 2020 Results Business Wire
Aug-04-20 05:53PM	Agilent Technologies At Upper End Of Buy Range With Earnings Due Investor's Business Daily
05:39PM	Luminex Scores Relative Strength Rating Upgrade Investor's Business Daily
09:41AM	Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More Zacks
09:07AM	Should You Buy Charles River Laboratories (CRL) Ahead of Earnings? Zacks
Jul-31-20 12:32PM	Should Investors Buy the Dip in Charles River Laboratories (CRL) Stock? Insider Monkey
Jul-29-20 12:33PM	Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Jul-24-20 07:39PM	Charles River Labs International Trading In New Buy Range With Quarterly Report On Tap Investor's Business Daily
Jul-22-20 09:19AM	Farallon plans to vote for the shareholder proposals at Toshiba's 181st Annual General Meeting PR Newswire
Jul-20-20 12:10PM	Can Charles River (CRL) Keep the Earnings Surprise Streak Alive? Zacks
Jul-15-20 04:42PM	IBD Stock Of The Day: Why This Medical Player Isn't Sweating The Pandemic Investor's Business Daily
Jul-14-20 08:30AM	Charles River Laboratories Schedules Second-Quarter 2020 Earnings Release and Conference Call Business Wire
Jul-13-20 05:03PM	Did Hedge Funds Make The Right Call On Charles River Laboratories International Inc. (CRL) ? Insider Monkey
Jul-09-20 03:24PM	The Charles River Laboratories International (NYSE:CRL) Share Price Is Up 147% And Shareholders Are Boasting About It Simply Wall St.
Jun-15-20 09:59AM	Edited Transcript of CRL earnings conference call or presentation 7-May-20 1:30pm GMT Thomson Reuters StreetEvents
Jun-11-20 10:05AM	Zacks.com featured highlights include: Lowes Companies, Charles River Laboratories International, Agilent Technologies and East West Zacks
09:02AM	Moving Average Crossover Alert: Charles River Laboratories International Zacks
Jun-10-20 10:25AM	4 GARP Stocks to Scoop Up for Maximum Returns Zacks
Jun-03-20 02:46AM	Hedge Funds Never Been This Bullish On Charles River Laboratories International (CRL) Insider Monkey
Jun-02-20 08:00AM	HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio Business Wire
07:58AM	Charles River Laboratories' Shares March Higher, Can It Continue? Zacks
Jun-01-20 08:00AM	Charles River Laboratories to Participate in Jefferies and William Blair Conferences Business Wire
May-30-20 10:54PM	Drugs standards group nixes plan to kick pharma's crab blood habit Reuters
11:42AM	Drugs standards group nixes plan to kick pharma's crab blood habit Reuters
May-28-20 11:00AM	Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells PR Newswire
May-21-20 07:13AM	A Rising Share Price Has Us Looking Closely At Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Ratio Simply Wall St.
May-09-20 09:12AM	At US$160, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List? Simply Wall St.
May-08-20 12:31AM	Charles River Laboratories International Inc (CRL) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 08:25AM	Charles River Laboratories (CRL) Q1 Earnings and Revenues Surpass Estimates Zacks +8.98%
07:00AM	Charles River Laboratories Announces First-Quarter 2020 Results Business Wire
Apr-30-20 12:34PM	Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-29-20 12:08PM	Why Horizon Kinetics is Bullish on Charles River Laboratories (CRL) Stock? Insider Monkey
Apr-20-20 03:24PM	Earnings Season Preview: Medpace Near Buy Zone With Quarterly Report Due Investor's Business Daily
Apr-19-20 03:54PM	Covid-19 Shines Spotlight on Clarivate GuruFocus.com
Apr-16-20 08:40AM	How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After Its Big Share Price Gain? Simply Wall St.
08:30AM	Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call Business Wire
Mar-30-20 08:30AM	Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology Business Wire
Mar-25-20 06:26AM	How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After The Share Price Drop? Simply Wall St. +8.38%
Mar-22-20 10:56PM	Is Charles River Laboratories International Inc. (CRL) Relatively A Good Stock To Buy? Insider Monkey
Mar-10-20 08:30AM	Charles River Laboratories To Participate In Barclays Global Healthcare Conference Business Wire
Mar-04-20 08:00AM	Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors Business Wire
Feb-14-20 09:31AM	Edited Transcript of CRL earnings conference call or presentation 11-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
Feb-13-20 07:11AM	What Did Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO Take Home Last Year? Simply Wall St.
06:37AM	Charles River Laboratories International, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Feb-12-20 12:00PM	Here's Why Momentum Investors Will Love Charles River Laboratories (CRL) Zacks
10:30AM	Charles River Labs Soars to a New High and More Strength Is Coming TheStreet.com
09:15AM	Charles River (CRL) Hits Fresh High: Is There Still Room to Run? Zacks
Feb-11-20 09:19AM	Charles River Laboratories Reports Q4 Above Our Expectations; Raising FVE on Solid 2020 Guidance Morningstar +9.88%
08:25AM	Charles River Laboratories (CRL) Q4 Earnings and Revenues Beat Estimates Zacks

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as bioanalysis, drug metabolism, pharmacokinetics, safety pharmacology, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company has a strategic partnership with PathoQuest SAS to establish a next generation sequencing based testing laboratory. Charles River Laboratories International, Inc. is based in Wilmington, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith David Ross	Corporate Executive VP & CFO	Jan 04	Sale	248.76	5,000	1,243,788	15,767	Jan 05 05:21 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 04	Option Exercise	123.73	6,739	833,841	18,095	Nov 05 11:46 AM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 04	Sale	250.28	6,739	1,686,627	11,356	Nov 05 11:46 AM
Barbo William D	Corporate Executive VP & CCO	Nov 03	Sale	236.29	2,150	508,015	9,821	Nov 05 03:51 PM
WALLMAN RICHARD F	Director	Nov 02	Buy	233.24	6,050	1,411,104	6,050	Nov 03 01:21 PM
WALLMAN RICHARD F	Director	Nov 02	Buy	232.96	1,150	267,902	31,715	Nov 03 01:21 PM
FOSTER JAMES C	Chairman, President and CEO	Nov 02	Sale	232.38	22,000	5,112,267	186,777	Nov 03 04:05 PM
MASSARO GEORGE	Director	Sep 14	Sale	219.91	1,943	427,284	9,441	Sep 15 05:47 PM
Girshick Birgit	Corporate Executive VP	Aug 20	Sale	213.51	933	199,205	22,852	Aug 21 10:48 AM
CHUBB STEPHEN D	Director	Aug 18	Sale	217.65	1,000	217,651	37,657	Aug 19 02:48 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 07	Option Exercise	111.41	3,441	383,353	5,855	Aug 10 03:20 PM
Smith David Ross	Corporate Executive VP & CFO	Aug 07	Option Exercise	144.67	3,304	477,990	24,071	Aug 10 04:18 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 07	Sale	216.60	3,456	748,555	2,399	Aug 10 03:20 PM
Smith David Ross	Corporate Executive VP & CFO	Aug 07	Sale	216.54	3,304	715,444	20,767	Aug 10 04:18 PM
Kochevar Deborah Turner	Director	Aug 07	Sale	216.24	2,319	501,467	6,728	Aug 11 10:39 AM
FOSTER JAMES C	Chairman, President and CEO	Aug 07	Sale	217.49	24,000	5,219,771	210,777	Aug 10 04:25 PM
MASSARO GEORGE	Director	May 22	Sale	173.40	941	163,168	11,884	May 26 02:37 PM
BERTOLINI ROBERT J	Director	May 20	Option Exercise	52.29	3,530	184,584	32,664	May 21 11:36 AM
BERTOLINI ROBERT J	Director	May 20	Sale	174.58	3,530	616,263	29,134	May 21 11:36 AM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 18	Sale	174.65	350	61,128	9,637	May 19 04:18 PM
FOSTER JAMES C	Chairman, President and CEO	May 18	Sale	175.00	17,435	3,051,125	229,894	May 19 04:14 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 15	Option Exercise	80.48	6,350	511,045	25,405	May 19 04:18 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 15	Sale	168.26	15,418	2,594,170	9,987	May 19 04:18 PM
Girshick Birgit	Corporate Executive VP	May 12	Sale	165.74	780	129,277	21,837	May 13 08:18 AM
FOSTER JAMES C	Chairman, President and CEO	May 11	Sale	162.53	17,446	2,835,433	249,329	May 13 11:02 AM
Smith David Ross	Corporate Executive VP & CFO	May 07	Sale	150.00	1,884	282,600	18,591	May 08 10:48 AM
Barbo William D	Corporate Executive VP & CCO	Mar 05	Option Exercise	102.56	12,467	1,278,677	30,201	Mar 06 03:50 PM
Barbo William D	Corporate Executive VP & CCO	Mar 05	Sale	164.35	13,966	2,295,300	16,235	Mar 06 03:50 PM
CHUBB STEPHEN D	Director	Feb 27	Option Exercise	55.17	7,170	395,572	42,005	Feb 28 10:28 AM
CHUBB STEPHEN D	Director	Feb 27	Sale	160.89	2,464	396,437	39,541	Feb 28 10:28 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 26	Option Exercise	73.70	25,124	1,851,639	311,899	Feb 27 02:45 PM
Smith David Ross	Corporate Executive VP & CFO	Feb 26	Option Exercise	73.70	4,188	308,656	24,663	Feb 27 02:48 PM
Smith David Ross	Corporate Executive VP & CFO	Feb 26	Sale	162.26	4,188	679,535	20,475	Feb 27 02:48 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 26	Sale	162.25	25,124	4,076,411	286,775	Feb 27 02:45 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 24	Option Exercise	97.80	44,303	4,332,960	333,349	Feb 26 10:15 AM
Smith David Ross	Corporate Executive VP & CFO	Feb 24	Option Exercise	98.02	8,211	804,860	29,065	Feb 25 11:29 AM
Smith David Ross	Corporate Executive VP & CFO	Feb 24	Sale	166.72	8,211	1,368,953	20,854	Feb 25 11:29 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 24	Sale	167.83	3,000	503,490	750	Feb 26 10:15 AM
FOSTER JAMES C	Chairman, President and CEO	Feb 24	Sale	166.70	44,303	7,385,433	289,046	Feb 26 10:15 AM
MILNE GEORGE M JR	Director	Feb 18	Option Exercise	55.17	7,170	395,572	34,207	Feb 19 10:41 AM
MILNE GEORGE M JR	Director	Feb 18	Sale	176.07	7,170	1,262,430	27,037	Feb 19 10:41 AM
WALLMAN RICHARD F	Director	Feb 14	Option Exercise	52.29	3,530	184,584	32,897	Feb 14 05:10 PM
WALLMAN RICHARD F	Director	Feb 14	Sale	174.29	3,530	615,258	29,367	Feb 14 05:10 PM
BERTOLINI ROBERT J	Director	Feb 13	Option Exercise	55.17	7,170	395,572	35,045	Feb 14 12:24 PM
WALLMAN RICHARD F	Director	Feb 13	Option Exercise	55.17	7,170	395,572	36,537	Feb 14 05:07 PM
BERTOLINI ROBERT J	Director	Feb 13	Sale	170.41	7,170	1,221,819	27,875	Feb 14 12:24 PM
Barbo William D	Corporate Executive VP & CCO	Feb 13	Sale	172.11	6,901	1,187,699	18,931	Feb 14 12:01 PM
FOSTER JAMES C	Chairman, President and CEO	Feb 13	Sale	171.90	15,000	2,578,440	298,064	Feb 14 03:06 PM
Girshick Birgit	Corporate Executive VP	Feb 13	Sale	172.05	900	154,845	23,714	Feb 14 09:43 AM
Smith David Ross	Corporate Executive VP & CFO	Feb 13	Sale	170.29	4,500	766,319	21,978	Feb 13 07:08 PM
WALLMAN RICHARD F	Director	Feb 13	Sale	172.02	7,170	1,233,391	29,367	Feb 14 05:07 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience